Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Canar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancers|October 14, 2022
Mutant <i>C. elegans</i> p53 Together with Gain-of-Function GLP-1/Notch Decreases UVC-Damage-Induced Germline Cell Death but Increases PARP Inhibitor-Induced Germline Cell DeathJorge Canar, Prima Manandhar-Sasaki, Jill Bargonetti
Cytokine|November 3, 2022
The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistanceJorge Canar, Kennedy Darling, Ryan Dadey, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 25, 2022
Exposing the Two Contrasting Faces of STAT2 in InflammationPhilip Duodu, Geohaira Sosa, Jorge Canar, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor SignalingJorge Canar, Madeline Bono, Amy Alvarado, et al.
Cancer Research|November 29, 2019
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast CancerGu Xiao, Devon Lundine, George K Annor, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancers|October 14, 2022
Mutant <i>C. elegans</i> p53 Together with Gain-of-Function GLP-1/Notch Decreases UVC-Damage-Induced Germline Cell Death but Increases PARP Inhibitor-Induced Germline Cell DeathJorge Canar, Prima Manandhar-Sasaki, Jill Bargonetti
Cytokine|November 3, 2022
The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistanceJorge Canar, Kennedy Darling, Ryan Dadey, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 25, 2022
Exposing the Two Contrasting Faces of STAT2 in InflammationPhilip Duodu, Geohaira Sosa, Jorge Canar, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor SignalingJorge Canar, Madeline Bono, Amy Alvarado, et al.
Cancer Research|November 29, 2019
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast CancerGu Xiao, Devon Lundine, George K Annor, et al.
Pageof 1